Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls

Carsten Heilmann1, Philippe Grandjean, Pál Weihe

  • 1Paediatric Clinic II, National University Hospital, Rigshospitalet, Copenhagen, Denmark.

Plos Medicine
|September 1, 2006
PubMed

Insights

Developmental exposure to polychlorinated biphenyls (PCBs) can impair children's immune responses to vaccinations. Early postnatal PCB exposure significantly reduced antibody levels for tetanus and diphtheria toxoids.

Area of Science:

  • Environmental Health
  • Immunology
  • Pediatrics

Background:

  • Developmental exposure to polychlorinated biphenyls (PCBs) is linked to immune deficiencies in children.
  • This study investigated the impact of prenatal and postnatal PCB exposure on antibody responses to childhood immunizations.

Purpose of the Study:

  • To assess the relationship between developmental polychlorinated biphenyl (PCB) exposure and antibody production following routine childhood vaccinations.
  • To determine if prenatal and postnatal PCB exposure affects immune response to diphtheria and tetanus toxoids.

Main Methods:

  • Two birth cohorts in the Faroe Islands with varying PCB exposure levels were studied.
  • Maternal serum and milk PCB concentrations measured prenatal exposure; child serum analyzed for antibodies and PCBs at 18 months and 7 years.
  • Antibody titers against tetanus and diphtheria toxoids were quantified and correlated with PCB exposure levels.

Main Results:

  • A 24.4% decrease in diphtheria toxoid antibody response at 18 months was observed for each doubling of cumulative PCB exposure.
  • Tetanus toxoid antibody response at 7 years decreased by 16.5% for each doubling of prenatal PCB exposure.
  • Early postnatal PCB exposure emerged as the strongest predictor of diminished vaccination response.

Conclusions:

  • Elevated perinatal polychlorinated biphenyl (PCB) exposure negatively affects immune responses to childhood vaccinations.
  • Reduced antibody production following immunization has clinical implications, highlighting the necessity of preventing exposure to immunotoxicants.
Abstract

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Cross-reactivity00:42

Cross-reactivity

Overview
Vaccinations01:51

Vaccinations

Overview
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...